On June 23, 2026, Alpha Tau Medical Ltd. announced the successful treatment of its first recurrent glioblastoma patient outside the United States using Alpha DaRT therapy at Hadassah University Medical Center in Israel. The company operates in the medical device industry and develops cancer treatment technologies.
